- Home
- GLDG vs ACHV Comparison
GLDG vs ACHV Comparison
Compare GLDG & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLDG
- ACHV
- Stock Information
- Founded
- GLDG 2009
- ACHV N/A
- Country
- GLDG Canada
- ACHV United States
- Employees
- GLDG N/A
- ACHV N/A
- Industry
- GLDG Precious Metals
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- GLDG Basic Materials
- ACHV Health Care
- Exchange
- GLDG Nasdaq
- ACHV Nasdaq
- Market Cap
- GLDG 159.6M
- ACHV 131.2M
- IPO Year
- GLDG N/A
- ACHV N/A
- Fundamental
- Price
- GLDG $0.81
- ACHV $2.55
- Analyst Decision
- GLDG Strong Buy
- ACHV Strong Buy
- Analyst Count
- GLDG 1
- ACHV 3
- Target Price
- GLDG $3.25
- ACHV $14.33
- AVG Volume (30 Days)
- GLDG 587.2K
- ACHV 666.0K
- Earning Date
- GLDG 10-10-2025
- ACHV 08-07-2025
- Dividend Yield
- GLDG N/A
- ACHV N/A
- EPS Growth
- GLDG N/A
- ACHV N/A
- EPS
- GLDG N/A
- ACHV N/A
- Revenue
- GLDG N/A
- ACHV N/A
- Revenue This Year
- GLDG N/A
- ACHV N/A
- Revenue Next Year
- GLDG N/A
- ACHV N/A
- P/E Ratio
- GLDG N/A
- ACHV N/A
- Revenue Growth
- GLDG N/A
- ACHV N/A
- 52 Week Low
- GLDG $0.71
- ACHV $1.84
- 52 Week High
- GLDG $1.06
- ACHV $5.31
- Technical
- Relative Strength Index (RSI)
- GLDG 56.49
- ACHV 46.32
- Support Level
- GLDG $0.78
- ACHV $2.37
- Resistance Level
- GLDG $0.82
- ACHV $2.56
- Average True Range (ATR)
- GLDG 0.02
- ACHV 0.12
- MACD
- GLDG -0.00
- ACHV 0.01
- Stochastic Oscillator
- GLDG 67.57
- ACHV 47.37
About GLDG GoldMining Inc.
GoldMining Inc is a mineral exploration company with a focus on the acquisition, exploration, and development of projects in Colombia, Brazil, the United States, Canada, and Peru. The principal projects are its La Mina Gold project and its Titiribi Gold-Copper project, located in Colombia; Crucero project, located in Peru; Sao Jorge, Batistao, located in Brazil; Yellowknife Gold Project, located in the Northwest Territories, Canada; and various other projects such as Cachoeira, Yarumalito, Whistler, Surubim, Montes Aureos and Trinta, Rea across different locations. The company has two operating segments, with U.S. GoldMining being one distinct operating segment and all other subsidiaries, or Others, being the second operating segment.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.